{
    "id": "c71d563c09",
    "level": "sentence",
    "abstract": [],
    "body_text": [
        {
            "text": "Human lung cancer is one of the most common malignant diseases and a leading cause of death annually in much of the developed world especially in China [1]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 152,
                    "end": 155,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "[1]"
                }
            ]
        },
        {
            "text": "Adenocarcinoma, the most common form of lung cancer, is one of main human malignant tumors, and its occurrence and development are highly correlated with inactivation of tumor suppressor genes. ",
            "section": "Introduction"
        },
        {
            "text": "Many genes play a role in negatively regulating lung tumor growth and apoptosis [2][3]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 80,
                    "end": 83,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2]"
                },
                {
                    "start": 83,
                    "end": 86,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "[3]"
                }
            ]
        },
        {
            "text": "Beyond that, there is little that can be definitively said. ",
            "section": "Introduction"
        },
        {
            "text": "The standard test to confirm multipotency is differentiation of the cells into osteoblasts, adipocytes, and chondrocytes, as well as myocytes and neurons. ",
            "section": "Introduction"
        },
        {
            "text": "A type of immunological cell, cytokine-induced killer (CIK) cells are a heterogeneous cell population that was first discovered in the 1990s and can be generated from lymphocytes co-cultured with an anti-CD3 antibody and many other cytokines in vitro [4][5]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 251,
                    "end": 254,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "[4]"
                },
                {
                    "start": 254,
                    "end": 257,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "[5]"
                }
            ]
        },
        {
            "text": "Numerous studies have demonstrated that CIK cells exhibit active and potent antitumor cytotoxicity against multifarious tumor cells in vitro and in vivo [6]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 153,
                    "end": 156,
                    "type": "bibr",
                    "ref_id": "b5",
                    "text": "[6]"
                }
            ]
        },
        {
            "text": "CIK cells alter the cytokine secretion profiles of dendritic cells, T cells, and natural killer cells to induce a more anti-inflammatory or tolerant phenotype. ",
            "section": "Introduction"
        },
        {
            "text": "This phenomenon has been documented in specific cells and tissues in living animals and their counterparts growing in cell culture [7].",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 131,
                    "end": 134,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "[7]"
                }
            ]
        },
        {
            "text": "It is well known that CIK cells used in biological systems are required to be anti-tumor. ",
            "section": "Introduction"
        },
        {
            "text": "More and more scientists are devoting themselves to the field of growth and differentiation of NCL-H157. ",
            "section": "Introduction"
        },
        {
            "text": "In vitro, CIK cells have greater expansion capability and a faster growth rate. ",
            "section": "Introduction"
        },
        {
            "text": "However, the conquest of NCL-H157 by CIK is still a great challenge to medical science. ",
            "section": "Introduction"
        },
        {
            "text": "In this study, we evaluated the inhibition of NCL-H157, which was significant with prolonged cellular doubling time and the possible molecular regulation mechanism of the proliferation of NCL-H157 by CIK.",
            "section": "Introduction"
        },
        {
            "text": "CIK cells were isolated and cultured according to standard protocol. ",
            "section": "CIK cells isolated and expanded?"
        },
        {
            "text": "Peripheral blood (50 mL) was drawn from the patients with heparin as an anticoagulant. ",
            "section": "CIK cells isolated and expanded?"
        },
        {
            "text": "Mononuclear cells were isolated by Ficoll-Conray (GE Healthcare, Fairfield, CT, USA) density gradient centrifugation, and then the remaining cells were washed twice with phosphate buffer saline (PBS). ",
            "section": "CIK cells isolated and expanded?"
        },
        {
            "text": "The viability and concentration of mononuclear cells were determined with trypan blue and a hemacytometer. ",
            "section": "CIK cells isolated and expanded?"
        },
        {
            "text": "Approximately 2.0\u00d710 6 /mL suspension and mononuclear cells were cultured in sixwell culture dishes with medium containing RPMI 1640 plus 1.0\u00d710 6 U/L human interferon gamma (IFN-\u03b3), 10% heat inactivated fetal bovine serum, 25 mM HEPES and 2 mM L-glutamine and incubated overnight at 37 \u00b0C in 5% carbon dioxide. ",
            "section": "CIK cells isolated and expanded?"
        },
        {
            "text": "After 24 hours, 50 \u03bcg/L monoclonal antibody (MAb) against CD3 and rhIL-2 (1\u00d710 6 U/L) were added. ",
            "section": "CIK cells isolated and expanded?"
        },
        {
            "text": "Fresh complete medium with rhIL-2 (1\u00d710 6 U/L) was changed every 2 to 3 days, and the cells were harvested on day 7, 14 and 21. ",
            "section": "CIK cells isolated and expanded?"
        },
        {
            "text": "All CIK cell cultures were tested for contamination (bacteria, fungi, and mycoplasma) throughout the study to assure culture quality and transfusion safety. ",
            "section": "CIK cells isolated and expanded?"
        },
        {
            "text": "The morphological changes were observed under an inverted phase contrast microscope at 200\u00d7 magnification.",
            "section": "CIK cells isolated and expanded?"
        },
        {
            "text": "In order to assay the percentages of cell surface antigen, FITC-and APC-stained cells were analyzed. ",
            "section": "CIK cell surface maker detected by flow cytometer measurement"
        },
        {
            "text": "After washing with ice-cold PBS two times, CIK cells were re-suspended in 200 mL binding buffer (10 mM HEPES/NaOH, pH 7.4, 150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 ) and co-incubated with 10 mL FITC-annexin V (25 g/mL) and 5 L propidium iodide (PI, 50 g/mL) in the absence of light for 15 minutes at room temperature. ",
            "section": "CIK cell surface maker detected by flow cytometer measurement"
        },
        {
            "text": "To confirm the cellular identity of cultured cells, CIK cells were subjected to fluorescence-activated cell sorting using CD3FITC, CD56APC positive markers. ",
            "section": "CIK cell surface maker detected by flow cytometer measurement"
        },
        {
            "text": "Finally, fluorescent intensities of stained cells were analyzed with a FACScalibur Flow cytometer (Becton Dickinson Corp., USA).",
            "section": "CIK cell surface maker detected by flow cytometer measurement"
        },
        {
            "text": "A 200 \u03bcL suspension of NCL-H157 cells per well was seeded in a 96-well plate at a density of 5\u00d710 4 cell/mL. ",
            "section": "3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) assay"
        },
        {
            "text": "NCL-H157 cells were grown for 12 hours after seeding, and then treated with CIK. ",
            "section": "3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) assay"
        },
        {
            "text": "After a 24-hour incubation, the medium was removed, and the cells were treated with CIK cells for 72 hours. ",
            "section": "3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) assay"
        },
        {
            "text": "Effector-to-target cell ratios (E/T ratio) ranged from 10:1, 20:1 and 30:1. ",
            "section": "3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) assay"
        },
        {
            "text": "NCL-H157 cells were re-suspended in a fresh culture medium after being centrifuged at 1000 rpm for 10 minutes; 20 \u03bcL MTS (5 mg/mL) was added to each well, and incubation was allowed to continue for an additional 4 hours. ",
            "section": "3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) assay"
        },
        {
            "text": "Finally, all media were removed by the centrifugation; 150 \u03bcL DMSO was added to each well and shaken for 10 minutes. ",
            "section": "3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) assay"
        },
        {
            "text": "The absorbance was read at a wavelength of 550 nm with a Benchmark Microplate Reader (Bio-Rad Corp. USA).",
            "section": "3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) assay"
        },
        {
            "text": "Western blotting analysis was performed to evaluate the influence of DMOG on the expression of VEGF in NCL-H157 cells. ",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells"
        },
        {
            "text": "The cells were cultured in regular medium with the addition of different concentrations of CIK (concentration of effector-to-target cell ratios (E/T ratio) ranged from 10:1, 20:1 and 30:1). ",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells"
        },
        {
            "text": "The total protein was harvested from the cultured cells according to standard protocols. ",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells"
        },
        {
            "text": "Then the protein concentration was measured with a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific, Waltham, MA, USA). ",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells"
        },
        {
            "text": "The cell lysates were separated on SDS-PAGE with 12% gels and transferred to nitrocellulose membranes. ",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells"
        },
        {
            "text": "The membranes were then incubated with primary antibodies of \u03b2-actin (1:1000, Santa Cruz, USA), VEGF (1:500, Santa Cruz, USA). ",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells"
        },
        {
            "text": "Then the membranes were incubated with gentle agitation for 2 hours at 37\u00b0C with horseradish peroxidase-conjugated secondary antibody diluted in 5% skim milk powder at 1:7500. ",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells"
        },
        {
            "text": "After washing three times in Tris-Buffered Saline-Tween-20 (Beyotime, China) (10 minutes each wash), the membranes were developed by an enhanced chemiluminescence (ECL) western blotting detection system. ",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells"
        },
        {
            "text": "Immunoreactive proteins were then detected by ChemiDoc MP System #170-8280 (Bio-Rad, USA). ",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells"
        },
        {
            "text": "Images were captured and analyzed by Quantity One software (Bio-Rad, USA).",
            "section": "Western blotting analysis to detect vascular endothelial growth factor (VEGF) in NCL-H157 treated by CIK cells",
            "entity_spans": [
                {
                    "start": 37,
                    "end": 49,
                    "type": "software",
                    "rawForm": "Quantity One",
                    "resp": "#annotator0",
                    "used": true,
                    "id": "c71d563c09-software-0",
                    "cert": "1.0"
                },
                {
                    "start": 60,
                    "end": 67,
                    "type": "publisher",
                    "rawForm": "Bio-Rad",
                    "resp": "#curator",
                    "id": "#c71d563c09-software-0"
                }
            ]
        },
        {
            "text": "All of the in vitro experiments were performed in triplicate, and data were presented as the mean \u00b1 standard deviation (SD) of three independent experiments. ",
            "section": "Statistical Analysis"
        },
        {
            "text": "Wherever appropriate, the data were subjected to statistical analysis by a one-way analysis of variance (ANOVA) test followed by the Student-Newman-Keuls test for comparison of all pairs of means. ",
            "section": "Statistical Analysis"
        },
        {
            "text": "A value of P<0.05 was considered to be statistically significant. ",
            "section": "Statistical Analysis"
        },
        {
            "text": "SPSS 11.5 for Windows software was used for the statistical analysis. ",
            "section": "Statistical Analysis",
            "entity_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "software",
                    "rawForm": "SPSS",
                    "resp": "#annotator0",
                    "used": true,
                    "id": "c71d563c09-software-1",
                    "cert": "1.0"
                },
                {
                    "start": 5,
                    "end": 9,
                    "type": "version",
                    "rawForm": "11.5",
                    "resp": "#annotator0",
                    "id": "#c71d563c09-software-1"
                }
            ]
        },
        {
            "text": "P-values <0.05 were considered significant.",
            "section": "Statistical Analysis"
        },
        {
            "text": "Ethics Statement: The study was approved by the insititutional review board (CWO) of Hebei Chest Hospital Ethics Committee, Shijiazhuang, The People's Republic of China. ",
            "section": "Statistical Analysis"
        },
        {
            "text": "All people provided written informed consent.",
            "section": "Statistical Analysis"
        },
        {
            "text": "Cultured CIK cells began to grow within 3 days and entered the proliferation stage within 5 days. ",
            "section": "Isolation and expansion of CIK cells with cytokine induced methods"
        },
        {
            "text": "Following 7 days of culture, the proliferation rate of CIK cells significantly grew faster and faster. ",
            "section": "Isolation and expansion of CIK cells with cytokine induced methods"
        },
        {
            "text": "After 21 days, cultured cells reached a density of (149.42\u00b14.59)\u00d710 7 . ",
            "section": "Isolation and expansion of CIK cells with cytokine induced methods",
            "ref_spans": [
                {
                    "start": 68,
                    "end": 69,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "7"
                }
            ]
        },
        {
            "text": "Cells were harvested and examined under an inverted microscope, which revealed that the cells grew as colonies in suspension (Figure 1). ",
            "section": "Isolation and expansion of CIK cells with cytokine induced methods",
            "ref_spans": [
                {
                    "start": 125,
                    "end": 134,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "(Figure 1"
                }
            ]
        },
        {
            "text": "Cell volume was markedly increased over time, and the survival rate of cultured cells was >95%.",
            "section": "Isolation and expansion of CIK cells with cytokine induced methods"
        },
        {
            "text": "Intensive and strict studies on the immune phenotype of CIK cells have been conducted. ",
            "section": "Immune phenotype of CIK cells"
        },
        {
            "text": "The CIK cells were analyzed by flow cytometric analysis and gated for granularity, size and surface markers. ",
            "section": "Immune phenotype of CIK cells"
        },
        {
            "text": "The gated cells were analyzed for the expression of cell membrane protein markers and found to be positive for the expression of a heterogeneous cell population, comprising CD3+CD56+, which are generally considered markers of CIK cells (Figure 2). ",
            "section": "Immune phenotype of CIK cells",
            "ref_spans": [
                {
                    "start": 236,
                    "end": 245,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "(Figure 2"
                }
            ]
        },
        {
            "text": "CD3+CD56+ T cells expression of CIK cells was 39.2\u00b1 1.1%.",
            "section": "Immune phenotype of CIK cells"
        },
        {
            "text": "The effects of CIK on the viability of NCL-H157 cells were evaluated by MTS assay (Figure 3). ",
            "section": "CIK inhibited the proliferation of NCL-H157 cells",
            "ref_spans": [
                {
                    "start": 82,
                    "end": 92,
                    "type": "figure",
                    "text": "(Figure 3)"
                }
            ]
        },
        {
            "text": "The results showed that exposure to CIK for 48 hours resulted in a dose-dependent increase in CIK, with a statistically significant difference between different groups. ",
            "section": "CIK inhibited the proliferation of NCL-H157 cells"
        },
        {
            "text": "Compared to the untreated control in DMEM/F12 cultured medium, the MTS assay showed CIK was more active against or with NCL-H157 cells in an ascending order. ",
            "section": "CIK inhibited the proliferation of NCL-H157 cells"
        },
        {
            "text": "Figure 2 shows the effect of CIK on the inhibition of NCL-H157. ",
            "section": "CIK inhibited the proliferation of NCL-H157 cells",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 8,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2"
                }
            ]
        },
        {
            "text": "As shown in Figure  2, when NCL-H157 was incubated with CIK, dose-dependent decreases of NCL-H157 viability from 21.4%, 54.0% and 71.3% were observed after increasing the CIK concentration of effector-to-target cell ratios (E/T ratio) ranging from 10:1, 20:1 and 30:1, respectively, compared with NCL-H157 in the control group. ",
            "section": "CIK inhibited the proliferation of NCL-H157 cells",
            "ref_spans": [
                {
                    "start": 12,
                    "end": 21,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure  2"
                }
            ]
        },
        {
            "text": "The concentration-dependent decreases of cell viability were observed as shown in Figure 2.  ",
            "section": "CIK inhibited the proliferation of NCL-H157 cells",
            "ref_spans": [
                {
                    "start": 82,
                    "end": 90,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2"
                }
            ]
        },
        {
            "text": "Also, the time-dependent decreases of cell viability were observed as in Figure 2. ",
            "section": "CIK inhibited the proliferation of NCL-H157 cells",
            "ref_spans": [
                {
                    "start": 73,
                    "end": 81,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2"
                }
            ]
        },
        {
            "text": "The cell viability was decreased from 66.8% to 79.8% to 86.9% after the incubation time 24 hours, 48 hours and 72 hours, respectively.",
            "section": "CIK inhibited the proliferation of NCL-H157 cells"
        },
        {
            "text": "To evaluate the influence of CIK on the expression of VEGF in NCL-H157, the protein levels of VEGF in NCL-H157 treated with different concentrations of CIK were detected by western blotting. ",
            "section": "Molecular expression changes in CIK co-cultured with hUCNCL-H157"
        },
        {
            "text": "The results showed the level of VEGF protein was enhanced in response to CIK treatment in a dose-dependent manner. ",
            "section": "Molecular expression changes in CIK co-cultured with hUCNCL-H157"
        },
        {
            "text": "VEGF is a molecule associated with the proliferation of NCL-H157 and the important proteins associated with it. ",
            "section": "Molecular expression changes in CIK co-cultured with hUCNCL-H157"
        },
        {
            "text": "In order to discover the molecular mechanism underlying the proliferation effect of CIK on NCL-H157 in vitro, we investigated the expressions of the proteins in NCL-H157 by western blotting (Figure 4  A). ",
            "section": "Molecular expression changes in CIK co-cultured with hUCNCL-H157",
            "ref_spans": [
                {
                    "start": 190,
                    "end": 203,
                    "type": "figure",
                    "text": "(Figure 4  A)"
                }
            ]
        },
        {
            "text": "The results showed that CIK co-cultured with NCL-H157 by transwell chamber for 48 hours resulted in the significant down-regulation of VEGF as compared to controls. ",
            "section": "Molecular expression changes in CIK co-cultured with hUCNCL-H157"
        },
        {
            "text": "We found increased VEGF levels in culture media of NCL-H157 cells. ",
            "section": "Molecular expression changes in CIK co-cultured with hUCNCL-H157"
        },
        {
            "text": "Irradiated NCL-H157 showed an inverse pattern, that is, decrease of VEGF.",
            "section": "Molecular expression changes in CIK co-cultured with hUCNCL-H157"
        },
        {
            "text": "To our knowledge, this is the first study of inhibition of NCL-H157 treated by CIK. ",
            "section": "Conclusions"
        },
        {
            "text": "In the event our study is viewed as merely phenomenological, we stress that our experiments were carefully designed to facilitate the inhibition of NCL-H157 cells and to record these effects, as well. ",
            "section": "Conclusions"
        },
        {
            "text": "Instead of focusing on NCL-H157 activity, we were more interested in following the inhibition of NCL-H157 that involves cell signal pathways and the breakout function of biological material-CIK cell. ",
            "section": "Conclusions"
        },
        {
            "text": "We found that the CD3+CD56+ subset of CIK cells was variably naturally active. ",
            "section": "Conclusions"
        },
        {
            "text": "The CD3+CD56+ subset could be polarized toward either Th1 or Th2 phenotype that, in turn, shapes its anti-tumor activity [8][9].",
            "section": "Conclusions",
            "ref_spans": [
                {
                    "start": 121,
                    "end": 124,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "[8]"
                },
                {
                    "start": 124,
                    "end": 127,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "[9]"
                }
            ]
        },
        {
            "text": "In this study, we assessed the NCL-H157 proliferation inhibited by CIK using the inverted phase contrast microscope and flow cytometer. ",
            "section": "Conclusions"
        },
        {
            "text": "NCL-H157 cells were detected after incubation with CIK at designed concentrations and times. ",
            "section": "Conclusions"
        },
        {
            "text": "CIK plays a critical role in providing the essential micro-environment for NCL-H157 at different CIK concentrations of effector-to-target cell ratios (E/T ratio) ranging from 10:1, 20:1 and 30:1 for 24 hours, 48 hours, and 72 hours, respectively. ",
            "section": "Conclusions"
        },
        {
            "text": "These images are shown in Figure  1. These results were further confirmed by MTS analysis as shown in Figure 2. The percentage of NCL-H157 in the control group was less than the treated group. ",
            "section": "Conclusions",
            "ref_spans": [
                {
                    "start": 26,
                    "end": 35,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figure  1"
                },
                {
                    "start": 102,
                    "end": 110,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2"
                }
            ]
        },
        {
            "text": "When the incubation time was prolonged to 72 hours, a marked Figure 3: Effects of CIK on NCL-H157 viability (n = 5). ",
            "section": "Conclusions",
            "ref_spans": [
                {
                    "start": 61,
                    "end": 69,
                    "type": "figure",
                    "text": "Figure 3"
                }
            ]
        },
        {
            "text": "Cell viability of NCL-H157 treated with different CIK concentrations of effector-totarget cell ratios (E/T ratio) ranged from 10:1, 20:1 and 30:1, for 24h, 48h, and 72h. ",
            "section": "Conclusions"
        },
        {
            "text": "(*, significant difference between the two groups, p < 0.05) ",
            "section": "Conclusions"
        },
        {
            "text": "Figure 4: A shows VEGF over-expression in NCL-H157 treated by CIK with western blotting analysis. ",
            "section": "Conclusions",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 8,
                    "type": "figure",
                    "text": "Figure 4"
                }
            ]
        },
        {
            "text": "In order to elucidate the pathway leading to proliferation, we examined the activation of VEGF, which was reported to initiate NCL-H157 generation by various stimuli. ",
            "section": "Conclusions"
        },
        {
            "text": "NCL-H157 treated with CIK were analyzed for the enzymatic activity by western blot. ",
            "section": "Conclusions"
        },
        {
            "text": "The expression of VEGF was not activated after CIK treatment in NCL-H157 was down-regulated. ",
            "section": "Conclusions"
        },
        {
            "text": "The activity of VEGF had significantly changed. ",
            "section": "Conclusions"
        },
        {
            "text": "B shows densitometric analysis of the levels of VEGF by an image analysis system. ",
            "section": "Conclusions"
        },
        {
            "text": "(n=6. Mean\u00b1SD. *P<0.01 vs control group) (ANOVA with subsequent multiple comparisons test)",
            "section": "Conclusions"
        },
        {
            "text": "decrease in the percentage of NCL-H157 cells was observed in CIK-treated groups. ",
            "section": "A B"
        },
        {
            "text": "The results obtained from MTS analysis suggest that CIK can induce lack of proliferation of NCL-H157, which is consistent with the observation with the inverted phase contrast microscope. ",
            "section": "A B"
        },
        {
            "text": "In the present study, however, the percentage of inhibition viability cells is not much more than that of the control group. ",
            "section": "A B"
        },
        {
            "text": "CIK cells establish an appropriate scaffold and a complex network of cytokines, adhesion molecules, and extracellular matrix proteins. ",
            "section": "A B"
        },
        {
            "text": "We showed that a VEGF pathway controls the proliferation of NCL-H157 treated by CIK [10][11]. ",
            "section": "A B",
            "ref_spans": [
                {
                    "start": 84,
                    "end": 88,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "[10]"
                },
                {
                    "start": 88,
                    "end": 92,
                    "type": "bibr",
                    "ref_id": "b10",
                    "text": "[11]"
                }
            ]
        },
        {
            "text": "NCL-H157 express some genes, suggesting the genicity and the superiority for clinical use. ",
            "section": "A B"
        },
        {
            "text": "CIK cells appear to have cytotoxic effects, indicating their superior role in the management of clinic treatment, and CIK cells were examined for safety and efficacy for carcinoma treatment [12][13][14][15]. ",
            "section": "A B",
            "ref_spans": [
                {
                    "start": 190,
                    "end": 194,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "[12]"
                },
                {
                    "start": 194,
                    "end": 198,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "[13]"
                },
                {
                    "start": 198,
                    "end": 202,
                    "type": "bibr",
                    "ref_id": "b13",
                    "text": "[14]"
                },
                {
                    "start": 202,
                    "end": 206,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "[15]"
                }
            ]
        },
        {
            "text": "We observed markedly enhanced anti-tumor cytotoxic activity of CIK cells after co-culture with NCL-H157. ",
            "section": "A B"
        },
        {
            "text": "Furthermore, CIK regulates NCL-H157 activity in a time-and concentration-dependent manner. ",
            "section": "A B"
        },
        {
            "text": "Effective adoptive cell transfer faces numerous challenges, such as systemic immune tolerance and tumor local immune escape. ",
            "section": "A B"
        },
        {
            "text": "The homing of immune cells to the tumor site is reduced, and the antitumor immune functions are inhibited by tumor microenvironment and immunomodulatory properties of suppressive cell populations [16][17][18]. ",
            "section": "A B",
            "ref_spans": [
                {
                    "start": 196,
                    "end": 200,
                    "type": "bibr",
                    "ref_id": "b15",
                    "text": "[16]"
                },
                {
                    "start": 200,
                    "end": 204,
                    "type": "bibr",
                    "ref_id": "b16",
                    "text": "[17]"
                },
                {
                    "start": 204,
                    "end": 208,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "[18]"
                }
            ]
        },
        {
            "text": "Collectively, these results demonstrate that VEGF signals coordinate and regulate the dynamics of CIK during VEGFinduced migration of NCL-H157 in varying states of differentiation. ",
            "section": "A B"
        },
        {
            "text": "Genetic experiments indicate that the VEGF pathway functions independently of pathways governing NCL-H157 inhibition. ",
            "section": "A B"
        },
        {
            "text": "Future studies using other gene expression should address the extent of the relative stiffness of NCL-H157 mobility as seen in our experiments and elucidate the understanding of the mechanism of NCL-H157 inhibition.",
            "section": "A B"
        },
        {
            "text": "The authors declare that they have no competing financial interests.",
            "section": "Competing financial interests:"
        }
    ]
}